News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
4,610 Results
Type
Article (1044)
Press Release (3566)
Multimedia
Podcasts (4)
Webinars (1)
Section
Business (2158)
Career Advice (4)
Deals (220)
Drug Delivery (1)
Drug Development (445)
Employer Resources (3)
FDA (122)
Job Trends (181)
News (2812)
Policy (238)
Tag
Academia (44)
Accelerated approval (1)
Adcomms (1)
Allergies (1)
Alliances (327)
ALS (1)
Alzheimer's disease (8)
Antibody-drug conjugate (ADC) (3)
Approvals (123)
Artificial intelligence (2)
Autoimmune disease (1)
Automation (1)
Bankruptcy (5)
Best Places to Work (135)
Biosimilars (2)
Breast cancer (2)
Cancer (33)
Cardiovascular disease (2)
Career advice (7)
CAR-T (4)
Cell therapy (9)
Clinical research (367)
Collaboration (11)
Compensation (1)
COVID-19 (30)
CRISPR (1)
C-suite (25)
Cystic fibrosis (1)
Data (50)
Depression (3)
Diabetes (5)
Diagnostics (41)
Diversity, equity & inclusion (1)
Drug pricing (3)
Duchenne muscular dystrophy (1)
Earnings (258)
Editorial (6)
Employer resources (3)
Events (433)
Executive appointments (34)
FDA (155)
Funding (18)
Gene editing (1)
Gene therapy (3)
GLP-1 (11)
Government (64)
Guidances (5)
Healthcare (149)
IgA nephropathy (2)
Immunology and inflammation (7)
Immuno-oncology (2)
Infectious disease (32)
Inflammatory bowel disease (3)
Influenza (1)
Interviews (1)
IPO (57)
Job creations (58)
Job search strategy (3)
Labor market (1)
Layoffs (24)
Leadership (3)
Legal (61)
Liver cancer (1)
Lung cancer (1)
Lymphoma (8)
Machine learning (1)
Management (1)
Manufacturing (4)
Medical device (94)
Medtech (94)
Mergers & acquisitions (171)
Metabolic disorders (9)
Multiple sclerosis (1)
Neurodegenerative disease (2)
Neuropsychiatric disorders (2)
Neuroscience (17)
NextGen: Class of 2026 (108)
Non-profit (65)
Obesity (4)
Opinion (4)
Pain (1)
Patents (1)
Patient recruitment (1)
People (1365)
Phase 1 (104)
Phase 2 (129)
Phase 3 (179)
Pipeline (25)
Policy (10)
Postmarket research (13)
Preclinical (43)
Radiopharmaceuticals (4)
Rare diseases (7)
Real estate (45)
Recruiting (1)
Regulatory (168)
Research institute (39)
Resumes & cover letters (2)
Schizophrenia (4)
Series A (7)
Series B (1)
Sickle cell disease (1)
Special edition (1)
Sponsored (1)
Startups (143)
Tariffs (2)
The Weekly (3)
Vaccines (10)
Venture capital (5)
Weight loss (1)
Date
Last 30 days (16)
Last 365 days (180)
2026 (18)
2025 (191)
2024 (194)
2023 (238)
2022 (386)
2021 (402)
2020 (413)
2019 (457)
2018 (332)
2017 (335)
2016 (324)
2015 (277)
2014 (192)
2013 (130)
2012 (102)
2011 (109)
2010 (126)
Location
Africa (27)
Alabama (2)
Asia (211)
Australia (31)
California (47)
Canada (12)
China (4)
Colorado (5)
Connecticut (5)
Delaware (7)
Europe (991)
Florida (5)
Georgia (2)
Hawaii (1)
Idaho (1)
Illinois (8)
India (1)
Indiana (8)
Iowa (1)
Japan (3)
Kentucky (1)
Maine (1)
Maryland (7)
Massachusetts (27)
Michigan (2)
Minnesota (2)
Nevada (2)
New Jersey (13)
New Mexico (1)
New York (37)
North Carolina (3)
Northern California (28)
Ohio (1)
Oklahoma (2)
Oregon (2)
Pennsylvania (4)
South America (8)
Southern California (10)
Texas (5)
United States (201)
Virginia (1)
Washington State (6)
4,610 Results for "richter helm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
December 9, 2025
·
11 min read
Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership
Nykode Therapeutics ASA announced that it has entered into a strategic manufacturing partnership with Richter-Helm BioLogics GmbH & Co KG to supply plasmid DNA for Nykode’s wholly owned and partnered product portfolio.
December 19, 2022
·
3 min read
Business
Gedeon Richter Selects Trial Interactive for Clinical Trial Management
TransPerfect Life Sciences, a leading global provider of solutions for product development and launch for the biopharmaceutical industry, announced that Gedeon Richter selected Trial Interactive’s award-winning eTMF platform and TI Collaborate eClinical solution for its upcoming clinical trials.
March 25, 2024
·
3 min read
Podcast
Billions More in M&A, Another Bidding War and More FDA Drama
Merck has made a $9.2 billion play for Cidara, and there’s another bidding war afoot, this one for sleep biotech Avadel. Meanwhile, Rick Pazdur has taken the helm at CDER while tensions run high between FDA Commissioner Marty Makary and Health Secretary RFK Jr.
November 19, 2025
·
1 min read
·
Heather McKenzie
Genetown
Gedeon Richter and Sumitomo Pharma Receive Positive CHMP Opinion for RYEQO® for Treatment of Endometriosis
Gedeon Richter Plc. (‘Richter’) together with Sumitomo Pharma America, Inc. (‘SMPA’) and Sumitomo Pharma Switzerland GmbH (‘SMPS’) today announce that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) has adopted a positive opinion recommending the approval of a Type II Variation application for RYEQO®.
September 15, 2023
·
4 min read
News
AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions
October 24, 2024
·
10 min read
Business
IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior Vice President, Commercial and Program Lead
IO Biotech announced that biopharma executive Christine Richter joined the company as SVP, Commercial and Program Lead for IO102-IO103, the company’s lead cancer vaccine candidate.
June 1, 2023
·
3 min read
Press Releases
Bio-Thera and Richter Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, for EU countries, UK, Switzerland and other selected countries
October 9, 2024
·
6 min read
Immunology and Inflammation
I&I Startup Bambusa Nabs $90M for Bispecific Antibodies
The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related indications.
February 14, 2025
·
1 min read
·
Dan Samorodnitsky
Neuropsychiatric disorders
Newleos Raises $93.5M to Advance Neuropsychiatric Cast-Offs from Roche
Helmed by Roche alums, Newleos Therapeutics is taking over four drugs dropped from the Swiss pharma’s pipeline in early 2024.
February 13, 2025
·
3 min read
·
Dan Samorodnitsky
1 of 461
Next